466 related articles for article (PubMed ID: 26564076)
1. PTEN hamartoma tumor syndrome.
Mester J; Charis E
Handb Clin Neurol; 2015; 132():129-37. PubMed ID: 26564076
[TBL] [Abstract][Full Text] [Related]
2. PTEN hamartoma tumor syndromes in childhood: description of two cases and a proposal for follow-up protocol.
Piccione M; Fragapane T; Antona V; Giachino D; Cupido F; Corsello G
Am J Med Genet A; 2013 Nov; 161A(11):2902-8. PubMed ID: 24123798
[TBL] [Abstract][Full Text] [Related]
3. Cowden syndrome.
Gustafson S; Zbuk KM; Scacheri C; Eng C
Semin Oncol; 2007 Oct; 34(5):428-34. PubMed ID: 17920899
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
Ngeow J; Sesock K; Eng C
Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
[TBL] [Abstract][Full Text] [Related]
5. Germline PTEN mutation in a family with Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome.
Zori RT; Marsh DJ; Graham GE; Marliss EB; Eng C
Am J Med Genet; 1998 Dec; 80(4):399-402. PubMed ID: 9856571
[TBL] [Abstract][Full Text] [Related]
6. Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome clinical features.
Pilarski R; Stephens JA; Noss R; Fisher JL; Prior TW
J Med Genet; 2011 Aug; 48(8):505-12. PubMed ID: 21659347
[TBL] [Abstract][Full Text] [Related]
7. Clinical presentation of PTEN mutations in childhood in the absence of family history of Cowden syndrome.
Busa T; Milh M; Degardin N; Girard N; Sigaudy S; Longy M; Olshchwang S; Sobol H; Chabrol B; Philip N
Eur J Paediatr Neurol; 2015 Mar; 19(2):188-92. PubMed ID: 25549896
[TBL] [Abstract][Full Text] [Related]
8. Clinical Implications for Germline PTEN Spectrum Disorders.
Ngeow J; Sesock K; Eng C
Endocrinol Metab Clin North Am; 2017 Jun; 46(2):503-517. PubMed ID: 28476234
[TBL] [Abstract][Full Text] [Related]
9. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome.
Marsh DJ; Kum JB; Lunetta KL; Bennett MJ; Gorlin RJ; Ahmed SF; Bodurtha J; Crowe C; Curtis MA; Dasouki M; Dunn T; Feit H; Geraghty MT; Graham JM; Hodgson SV; Hunter A; Korf BR; Manchester D; Miesfeldt S; Murday VA; Nathanson KL; Parisi M; Pober B; Romano C; Eng C
Hum Mol Genet; 1999 Aug; 8(8):1461-72. PubMed ID: 10400993
[TBL] [Abstract][Full Text] [Related]
10. Bannayan-Riley-Ruvalcaba syndrome: further delineation of the phenotype and management of PTEN mutation-positive cases.
Hendriks YM; Verhallen JT; van der Smagt JJ; Kant SG; Hilhorst Y; Hoefsloot L; Hansson KB; van der Straaten PJ; Boutkan H; Breuning MH; Vasen HF; Bröcker-Vriends AH
Fam Cancer; 2003; 2(2):79-85. PubMed ID: 14574156
[TBL] [Abstract][Full Text] [Related]
11. Mutation-positive and mutation-negative patients with Cowden and Bannayan-Riley-Ruvalcaba syndromes associated with distinct 10q haplotypes.
Pezzolesi MG; Li Y; Zhou XP; Pilarski R; Shen L; Eng C
Am J Hum Genet; 2006 Nov; 79(5):923-34. PubMed ID: 17033968
[TBL] [Abstract][Full Text] [Related]
12. PTEN Mutation Identified in Patient Diagnosed with Simultaneous Multiple Cancers.
Won HS; Chang ED; Na SJ; Whang IY; Lee DS; You SH; Kim YS; Kim JS
Cancer Res Treat; 2019 Jan; 51(1):402-407. PubMed ID: 29510612
[TBL] [Abstract][Full Text] [Related]
13. Novel PTEN germline mutation in a family with mild phenotype: difficulties in genetic counseling.
Busa T; Chabrol B; Perret O; Longy M; Philip N
Gene; 2013 Jan; 512(2):194-7. PubMed ID: 23124040
[TBL] [Abstract][Full Text] [Related]
14. Novel dermatological and skeletal features associated with PTEN variant in PTEN hamartoma tumor syndrome.
Comeau D; Allain V; Maillet-Lebel N; Ben Amor M
Eur J Med Genet; 2023 Aug; 66(8):104798. PubMed ID: 37307869
[TBL] [Abstract][Full Text] [Related]
15. Imaging of PTEN-related abnormalities in the central nervous system.
Dhamija R; Hoxworth JM
Clin Imaging; 2020 Apr; 60(2):180-185. PubMed ID: 31927175
[TBL] [Abstract][Full Text] [Related]
16. Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome.
Orloff MS; Eng C
Oncogene; 2008 Sep; 27(41):5387-97. PubMed ID: 18794875
[TBL] [Abstract][Full Text] [Related]
17. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.
Marsh DJ; Coulon V; Lunetta KL; Rocca-Serra P; Dahia PL; Zheng Z; Liaw D; Caron S; Duboué B; Lin AY; Richardson AL; Bonnetblanc JM; Bressieux JM; Cabarrot-Moreau A; Chompret A; Demange L; Eeles RA; Yahanda AM; Fearon ER; Fricker JP; Gorlin RJ; Hodgson SV; Huson S; Lacombe D; Eng C
Hum Mol Genet; 1998 Mar; 7(3):507-15. PubMed ID: 9467011
[TBL] [Abstract][Full Text] [Related]
18. Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations.
Yehia L; Ni Y; Sesock K; Niazi F; Fletcher B; Chen HJL; LaFramboise T; Eng C
PLoS Genet; 2018 Apr; 14(4):e1007352. PubMed ID: 29684080
[TBL] [Abstract][Full Text] [Related]
19. Esophageal cancer in a family with hamartomatous tumors and germline PTEN frameshift and SMAD7 missense mutations.
Sherman SK; Maxwell JE; Qian Q; Bellizzi AM; Braun TA; Iannettoni MD; Darbro BW; Howe JR
Cancer Genet; 2015; 208(1-2):41-6. PubMed ID: 25554686
[TBL] [Abstract][Full Text] [Related]
20. PTEN hamartoma tumor syndrome: clinical risk assessment and management protocol.
Ngeow J; Eng C
Methods; 2015 May; 77-78():11-9. PubMed ID: 25461771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
